Kenichi Hirabayashi

9PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2025
TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.

Zenta Seto, Minehiko Inomata, Akira Noguchi

|Jul 25, 2022
Background features in the cytology of pancreatic neoplasms.

Kenichi Hirabayashi, Tsubasa Saika, Naoya Nakamura

|May 19, 2021
Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.

Ryuji Komine, Motohiro Kojima, Genichiro Ishi

|Oct 24, 2020
Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma.

Masashi Morimachi, Kenichi Hirabayashi, Yumi Takanashi

|Aug 09, 2020
Guidance for diagnosing autoimmune pancreatitis with biopsy tissues.

Kenji Notohara, Terumi Kamisawa, Noriyoshi Fukushima

|May 31, 2020
Cancer-associated fibroblasts are a useful cytological finding for diagnosing pancreatic ductal adenocarcinoma.

Tsubasa Saika, Kenichi Hirabayashi, Hitoshi Itoh

Pageof 2